Institute for Cancer Research
Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded.
The Institute has internationally strong research groups within biochemistry, cell and tumor biology, genetics, radiation biology, immunology and cancer prevention. For more than 30 years there has been a close interaction between researchers at the Institute and cancer surgeons, oncologists and pathologists. This emphasis on translational science has resulted in numerous clinical protocols based on in-house research, and the Institute is a key partner in the Comprehensive Cancer Center, organizationally under the Division of Surgery and Cancer Treatment at Oslo University Hospital.
Scientific production - Institute for Cancer Research
WiBEC (Wireless In-Body Environment Communications), an Innovative Training Network for 16 young researchers, has been selected for funding by the European Commission under the H2020- MARIE Sklodowska-CURIE ACTIONS (MSCA-ITN-2015).
The beneficiaries are Oslo University Hospital with professor Ilangko Balasingham (photo) as coordinator, Sorin CRM, France, Universitat Politechnica de Valencia, Spain, Technische Universität Dresden, Germany, Ovesco AG, Germany, Norges tekninsk-naturvitenskapelige universitet, Norway, ValoTec, France, and Instituto de Investigación Sanitaria La Fe, Spain.
The latest OUS research blog is written by Petter Strømme and Gro Anita Gauslå from the Department of Clinical Neurosciences for Children at the Woman and Children's Division at OUS. The blog is entitled "Grave metabolic diseases may be treated" and discusses how chronic and incurable diseases that affect children's nervous system now may be treated with increasingly good results.
Åsmund Eikenes from Harald Stenmark's lab at the department of Molecular Cell Biology has written a column in the careers section of the May 6th edition of Nature (journal impact factor 42.4). The article is entitled "Visual maps bring research to life".
In the short essay, Åsmund argues that scientists could benefit from actively using techniques from storytelling to improve their scientific work.
About 40 teams from Oslo University Hospital participated in this year's Holmenkollstafetten, Norway's largest sport event in number of participants (about 51 000). With 15 members on each team, each running between 390 and 2800 meters, this relay race acts as an inspiring annual event, triggering activities at the work places before and after the race, contributing to the improvement of the general public health at the institution. It is not the running of the particular stretch on race day that is important in this respect, it is the training leading up to the event that can make a difference. The Holmenkollstafetten has become an important social happening for many departments at the hospital.
Three scientists received awards for their outstanding work at a ceremony taking place at Oslo University Hospital April 24th. The major prize - the "Excellent Researcher Award" - went to professor Anne-Lise Børresen-Dale. Jan Terje Andersen and Jon Arne Dahl both received the "Early Career Award". The prize money - 300.000 and 150.000 NOK respectively - is earmarked for research activities. This is the third year such prizes have been distributed in order to honour excellent scientific achievements.
In a recent OUS research blog article (in Norwegian) Anja Nilsen (PhD) from Heidi Lyng's Clinical Radiation Biology group at the Departement of Radiation Biology at the Institute for Cancer Research writes about cancer treatment and how the use of RNA as biomarkers may be useful in order to give more precise radiation doses as well as to improve the targeting of chemotherapy.
New EU H2020- MARIE Sklodowska-CURIE ACTIONS project coordinated by The Intervention Centre
May 27, 2015
Improved methods for the treatment of metabolic diseases affecting children's nervous system
May 20, 2015
Inst. for Cancer Research
Journal Impact Factor > 5, first or last author from the Institute for Cancer Research
Photochemical activation of MH3-B1/rGel; a HER2-targeted treatment approach for ovarian cancer
Oncotarget (in press)
Repeated ER-endosome contacts promote endosome translocation and neurite outgrowth
Nature, 520 (7546), 234-8